Actual Medicinal Product (AMP) Cyproheptadine 4mg tablets (Special Order)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the product PERIACTIN® 4mg Tablets (TEVA UK Limited).

Generic
Cyproheptadine
Formulation
Cyproheptadine 4mg tablets
  • Cyproheptadine
    • Cyproheptadine 4mg tablets

      • Cyproheptadine 4mg tablets (Special Order)



Related Formulations (1)

compatible_special_measures logo Cyproheptadine 4mg tablets